title: E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene.
abstract: This study assesses the possible associations between postmenopausal therapy (hormone therapy, raloxifene, and tibolone) and E-cadherin expression in normal cervical Papanicolaou smears (squamous, glandular, and metaplastic cells). E-cadherin immunostaining was less intense in metaplastic cells of women on tibolone, whereas hormone therapy and raloxifene were not associated with altered E-cadherin expression.
authors: Menopause Clinic, 2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieio Hospital, Athens, Greece.
authors: Vasileios
authors: V
authors: Sioulas
authors: George
authors: G
authors: Christodoulakos
authors: Irene
authors: I
authors: Lambrinoudaki
authors: Ekaterini
authors: E
authors: Politi
authors: Theodoros N
authors: TN
authors: Sergentanis
authors: George
authors: G
authors: Creatsas
mesh_terms: D000368:Aged; D015820:Cadherins / Q000032:analysis*; D002584:Cervix Uteri / Q000737:chemistry / Q000187:drug effects* / Q000473:pathology; D004847:Epithelial Cells / Q000737:chemistry / Q000187:drug effects* / Q000473:pathology; D020847:Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008679:Metaplasia; D008875:Middle Aged; D009652:Norpregnenes / Q000009:adverse effects / Q000627:therapeutic use*; D065006:Papanicolaou Test; D017698:Postmenopause / Q000378:metabolism*; D020849:Raloxifene Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000737:chemistry / Q000209:etiology; D014626:Vaginal Smears; D002578:Uterine Cervical Dysplasia / Q000737:chemistry / Q000209:etiology
chemical_list: D015820:Cadherins; D020847:Estrogen Receptor Modulators; D009652:Norpregnenes; D020849:Raloxifene Hydrochloride; C027385:tibolone